Page 134 - 2018_09-Mondo

D. Fuerst et al. References
1. Passweg JR, Baldomero H, Bader P, et al. Use of haploidentical stem cell transplanta- tion continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant. 2017;52(6):811-817.
2. Armand P, Gibson CJ, Cutler C, et al. A dis- ease risk index for patients undergoing allo- geneic stem cell transplantation. Blood. 2012;120(4):905-913.
3. Kollman C, Spellman SR, Zhang MJ, et al. The effect of donor characteristics on sur- vival after unrelated donor transplantation for hematologic malignancy. Blood. 2016;127(2):260-267.
4. Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363(22):2091-2101.
5. Iacobelli S. Suggestions on the use of statis- tical methodologies in studies of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2013;48 (Suppl 1):S1-37.
6. Zhou B, Fine J, Latouche A, Labopin M. Competing risks regression for clustered data. Biostatistics. 2012;13(3):371-383.
7. Robin M, Porcher R, Ades L, et al. HLA- matched allogeneic stem cell transplanta- tion improves outcome of higher risk myelodysplastic syndrome. A prospective study on behalf of SFGM-TC and GFM. Leukemia. 2015;29(7):1496-1501.
8. Wingard JR, Majhail NS, Brazauskas R, et al. Long-term survival and late deaths after allogeneic hematopoietic cell transplanta- tion. J Clin Oncol. 2011;29(16):2230-2239.
9. Fuerst D, Mueller C, Beelen DW, et al. Time-dependent effects of clinical predic- tors in unrelated hematopoietic stem cell transplantation. Haematologica. 2016;101 (2):241-247.
10. Gratwohl A, Stern M, Brand R, et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer. 2009;115 (20):4715-4726.
11. Grambsch P, Therneau T. Proportional haz- ards tests and diagnostics based on weight- ed residuals. Biometrika. 1994;81(3):515- 526.
12. Anderson JA, Senthilselvan A. A two-step regression model for hazard functions. J
Applied Stat. 1982;31(1):44-51.
13. Zhang MH, Pasquini M, Ahn KW.
Regression models in bone marrow trans- plantation - a case study. In: Klein J, Houwelingen H, Ibrahim J, Scheike TH, editors. Handbook of Survival Analysis. London, New York: CRC Press; 2014. 243- 262.
14. Carreras E, Diaz-Ricart M. The role of the endothelium in the short-term complica- tions of hematopoietic SCT. Bone Marrow Transplant. 2011;46(12):1495-1502.
15. Paczesny S, Diaz-Ricart M, Carreras E, Cooke KR. Translational research efforts in biomarkers and biology of early transplant- related complications. Biol Blood Marrow Transplant. 2011;17(1 Suppl):S101-S108.
16. Palomo M, Diaz-Ricart M, Carbo C, et al. Endothelial dysfunction after hematopoiet- ic stem cell transplantation: role of the con- ditioning regimen and the type of trans- plantation. Biol Blood Marrow Transplant. 2010;16(7):985-993.
17. Gyurkocza B, Sandmaier BM. Conditioning regimens for hematopoietic cell transplan- tation: one size does not fit all. Blood. 2014;124(3):344-353.
18. Cheuk DK. Optimal stem cell source for allogeneic stem cell transplantation for hematological malignancies. World J Transplant. 2013;3(4):99-112.
19. Couban S, Simpson DR, Barnett MJ, et al. A randomized multicenter comparison of bone marrow and peripheral blood in recip- ients of matched sibling allogeneic trans- plants for myeloid malignancies. Blood. 2002;100(5):1525-1531.
20. Flowers ME, Parker PM, Johnston LJ, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood. 2002;100(2): 415-419.
21. Finke J, Schmoor C, Bethge WA, et al. Long-term outcomes after standard graft- versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised con- trolled trial. Lancet Haematol. 2017;4(6): e293-e301.
22. Lee SJ, Klein J, Haagenson M, et al. High- resolution donor-recipient HLA matching contributes to the success of unrelated
donor marrow transplantation. Blood.
2007;110(13):4576-4583.
23. Craddock C, Nagra S, Peniket A, et al.
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia. Haematologica. 2010;95(6):989- 995.
24. Remberger M, Ackefors M, Berglund S, et al. Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study. Biol Blood Marrow Transplant. 2011;17(11): 1688-1697.
25. Abdul Wahid SF, Ismail NA, Mohd-Idris MR, et al. Comparison of reduced-intensity and myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and acute lymphoblastic leukemia: a meta-analysis. Stem Cells Dev. 2014;23(21):2535-2552.
26. Sorror M, Storer B, Sandmaier BM, et al. Hematopoietic cell transplantation-comor- bidity index and Karnofsky performance status are independent predictors of mor- bidity and mortality after allogeneic non- myeloablative hematopoietic cell trans- plantation. Cancer. 2008;112(9):1992-2001.
27. Anasetti C, Logan BR, Lee SJ, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med. 2012;367(16):1487-1496.
28. Gratwohl A, Brand R, Frassoni F, et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant. 2005;36(9):757-769.
29. Gratwohl A. The EBMT risk score. Bone Marrow Transplant. 2012;47(6):749-756.
30. Zwaan FE, Hermans J, Barrett AJ, Speck B. Bone marrow transplantation for acute nonlymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.). Br J Haematol. 1984;56(4):645-653.
31. Buchholz A, Sauerbrei W. Comparison of procedures to assess non-linear and time- varying effects in multivariable models for survival data. Biom J. 2011;53(2):308-331.
32. Thomas L, Reyes EM. Tutorial: survival estimation for Cox regression models with time-varying coefficients using SAS and R. J Stat Software. 2014;61(1):1-16.
1534
haematologica | 2018; 103(9)